Mutations in MPNs to “interfere-on”

John Mascarenhas

doi:10.1182/blood.2021013432

Mutations in MPNs to “interfere-on”

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	2156-2157
Number of pages	2
Journal	Blood
Volume	138
Issue number	22
DOIs	https://doi.org/10.1182/blood.2021013432
State	Published - 2 Dec 2021

Access to Document

10.1182/blood.2021013432

Cite this

@article{b0b975b8069a47a29cc920b096713777,

title = "Mutations in MPNs to “interfere-on”",

author = "John Mascarenhas",

note = "Funding Information: Conflict-of-interest disclosure: J.M. receives contracted research funding paid to the institution from Incyte, Novartis, Abbvie, Geron, BMS, Forbius, Merck, and CTI Bio and advisory board/consulting fees from Incyte, CTI Bio, Constellation, Roche, BMS, Sierra Oncology, Novartis, PharmaEssentia, Geron, and Abbvie.",

year = "2021",

month = dec,

day = "2",

doi = "10.1182/blood.2021013432",

language = "English",

volume = "138",

pages = "2156--2157",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "22",

}

TY - JOUR

T1 - Mutations in MPNs to “interfere-on”

AU - Mascarenhas, John

N1 - Funding Information: Conflict-of-interest disclosure: J.M. receives contracted research funding paid to the institution from Incyte, Novartis, Abbvie, Geron, BMS, Forbius, Merck, and CTI Bio and advisory board/consulting fees from Incyte, CTI Bio, Constellation, Roche, BMS, Sierra Oncology, Novartis, PharmaEssentia, Geron, and Abbvie.

PY - 2021/12/2

Y1 - 2021/12/2

UR - http://www.scopus.com/inward/record.url?scp=85120314372&partnerID=8YFLogxK

U2 - 10.1182/blood.2021013432

DO - 10.1182/blood.2021013432

M3 - Editorial

C2 - 34854876

AN - SCOPUS:85120314372

SN - 0006-4971

VL - 138

SP - 2156

EP - 2157

JO - Blood

JF - Blood

IS - 22

ER -